Heather Hazzan/SELF
FDA panel recommends OK for Pfizer’s vaccine for kids 5 to 11
A federal vaccine advisory panel on Tuesday recommended authorizing Pfizer’s COVID-19 vaccine for children ages 5 to 11, a decision that means as soon as next week everyone in the United States over age 5 is expected to be eligible for a shot.





